Libra Review | Choose Better

Be a part of me at my shows at #APISecure2022 the place I will likely be surrounded by far smarter individuals on API safety. It is a digital occasion, so it's best to definitely have the ability to enroll.  so, there's going to be just a bit bit about #FHIR: On Wednesday I will likely be on a panel with Alissa and Grahame - The State of FHIR API Safety in Healthcare On Thursday Grahame will likely be talking - Securing FHIR APIs in Healthcare After Grahame I will likely be talking - Designing and Implementing a FHIR API Safety Plan BUT the extra necessary is ALL the opposite periods. Defending a FHIR API begins with fundamentals of defending an API. So please safe your #FHIR API and Apps. Begin with good API Safety fundamentals. You can view the original post here Show Original: https://librareview.com/api-safety-convention-on-fhir/

Marc Leighton, VP of Product at Florence Healthcare Prior to COVID, major technological transformation initiatives were already underway at many clinical trial sites, sponsors, and contract research organizations (CROs.) But the move to decentralized trials accelerated dramatically in 2020 and 2021–and it’s not slowing down.  Survey data from WCG Avoca shows that research sites and sponsors expect 89% of clinical trials to qualify as a hybrid, with a mix of decentralized technology and in-person visits.  But what will these decentralized clinical trials (DCTs) look like? I’d like to share some bold predictions for DCTs in 2022 (and beyond!):  Sites and sponsors shouldn’t be locked into a zero-sum game against one another. In 2022, they’ll be unified by complementary technology and the common purpose of getting cures to market.  By the end of the year, I expect the majority of sites will have an electronic Investigator Site File (eISF) and electronic informed consent (eConsent)....